Private company generic insulin manufacturer global markets 20 revenue?

Could you clarify what you’re looking for?

- Do you want private companies that manufacture insulin biosimilars/generics with a global market footprint, and their approximate revenues?
- Or are you asking for a market overview of insulin manufacturers (including public companies) and which have around $20B in revenue?
- Also, by “20 revenue,” do you mean about $20 billion in annual revenue, or something else?

Context: most large insulin players (Novo Nordisk, Eli Lilly, Sanofi) are publicly listed and well above that scale. Insulin biosimilars are being developed by various companies, many of which aren’t private or don’t disclose such high revenues. If you confirm the exact ask, I can tailor a concise list or profile.